1 |
Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, et al. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature 2012;485: 260-263.
DOI
ScienceOn
|
2 |
Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, Corbacioglu A, et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 2005;106:3740-3746.
DOI
ScienceOn
|
3 |
Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood 2011;118:6153-6163.
DOI
ScienceOn
|
4 |
Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim TS, et al. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. Int J Oncol 2009;34: 1165-1171.
|
5 |
Tucker T, Friedman JM. Pathogenesis of hereditary tumors: beyond the "two-hit" hypothesis. Clin Genet 2002;62:345-357.
DOI
ScienceOn
|
6 |
Liang H, Zhang J, Shao C, Zhao L, Xu W, Sutherland LC, et al. Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues. J Exp Clin Cancer Res 2012;31:36.
DOI
|
7 |
Pezzi A, Moraes L, Valim V, Amorin B, Melchiades G, Oliveira F, et al. DNMT3A mutations in patients with acute myeloid leukemia in South Brazil. Adv Hematol 2012;2012:697691.
|